William Desmarais
Geen lopende functies
Profiel
William Desmarais served as Vice President-Business Development at Momenta Pharmaceuticals, Inc. from 2017 to 2021.
He then worked as Chief Business Officer at TScan Therapeutics, Inc. from 2021 to 2023.
Desmarais holds an MBA from Massachusetts Institute of Technology, a doctorate from Brandeis University, and an undergraduate degree from Purdue University.
Eerdere bekende functies van William Desmarais
| Bedrijven | Functie | Einde |
|---|---|---|
| TSCAN THERAPEUTICS, INC. | Corporate Officer/Principal | 01-01-2023 |
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-02-2021 |
Opleiding van William Desmarais
| Brandeis University | Doctorate Degree |
| Massachusetts Institute of Technology | Masters Business Admin |
| Purdue University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TSCAN THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
